en
2011 Media releases
| 12/21/11 | Novartis announces termination of ALTITUDE study with Rasilez®/ Tekturna® in high-risk patients with diabetes and renal impairment |  |
| 10/04/11 | Improved Access for TOBI* PODHALER* in Québec | |
| 09/27/11 | Seventh annual Toronto-Montreal bicycle "Ride for the Cure" raises funds for breast cancer research and inspires Novartis employees to keep themselves healthy | |
| 09/14/11 | Health Canada approves PrLucentis* to treat vision loss resulting from diabetic macular edema (DME) | |
| 09/13/11 | First medication for children with brain tumours approved in Canada | |
| 08/18/11 | Health Canada approves PrLucentis* to treat vision loss resulting from retinal vein occlusion (RVO) | |
| 06/27/11 | Tasigna* receives Canadian approval - A significant improvement over the gold standard in treating a white blood cell cancer | |
| 06/14/11 | Novartis candidate vaccine 4CMenB shows significant potential in providing broad coverage against meningococcal serogroup B infections | |
| 05/27/11 | Novartis employees contribute volunteer efforts to 15 Montreal-area organizations as part of company’s 15th annual Community Partnership Day | |
| 03/10/11 | First oral treatment for people with multiple sclerosis approved in Canada Shown to significantly reduce relapses and slow disease progression | |
| 02/23/11 | Health Canada Approves FLUAD®, New Influenza Vaccine for Seniors | |
DISCLAIMER FOR ARCHIVES
The information in our Media Release Archives was factually accurate on the date of publication. This information remains on our website for historical purposes only. Novartis Pharmaceuticals Canada Inc. assumes no duty to update the information to reflect subsequent developments. Readers should not rely upon this information as current or accurate after their publication dates.
ABOUT NOVARTIS
On March 7th, 1996 Sandoz and Ciba-Geigy, the two Swiss-based chemical/life sciences giants, became Novartis
Our Products
We are a leader in offering medicines to protect health, cure disease and improve well-being.